ENTRY       D00107                      Drug
NAME        Tacrolimus (USP/INN);
            Tacrolimus hydrate (JP18);
            Prograf (TN);
            Protopic (TN)
PRODUCT     ASTAGRAF XL (Astellas Pharma US)
            ENVARSUS (Veloxis Pharmaceuticals)
            PROGRAF (Astellas Pharma US)
            PROTOPIC (LEO Pharma)
            TACROLIMUS (Padagis Israel Pharmaceuticals)
  GENERIC   TACROLIMUS (A-S Medication Solutions)
            TACROLIMUS (Accord Healthcare)
            TACROLIMUS (Accord Healthcare)
            TACROLIMUS (Ajenat Pharmaceuticals LLC)
            TACROLIMUS (American Health Packaging)
            TACROLIMUS (Aphena Pharma Solutions - Tennessee)
            TACROLIMUS (Ascend Laboratories)
            TACROLIMUS (BPI LABS LLC)
            TACROLIMUS (Belcher Pharmaceuticals)
            TACROLIMUS (Biocon Pharma)
            TACROLIMUS (BionPharma Inc.,)
            TACROLIMUS (Bryant Ranch Prepack)
            TACROLIMUS (Bryant Ranch Prepack)
            TACROLIMUS (Bryant Ranch Prepack)
            TACROLIMUS (Bryant Ranch Prepack)
            TACROLIMUS (Bryant Ranch Prepack)
            TACROLIMUS (CONCORD BIOTECH LIMITED)
            TACROLIMUS (Cardinal Health 107)
            TACROLIMUS (Cardinal Health 107)
            TACROLIMUS (Civica)
            TACROLIMUS (Dr. Reddy's Laboratories Limited)
            TACROLIMUS (E. Fougera & Co. a division of Fougera Pharmaceuticals)
            TACROLIMUS (Encube Ethicals Private Limited)
            TACROLIMUS (Glenmark Pharmaceuticals)
            TACROLIMUS (Glenmark Pharmaceuticals)
            TACROLIMUS (Golden State Medical Supply)
            TACROLIMUS (Lupin Pharmaceuticals)
            TACROLIMUS (Major Pharmaceuticals)
            TACROLIMUS (Major Pharmaceuticals)
            TACROLIMUS (Mayne Pharma)
            TACROLIMUS (Mylan Institutional)
            TACROLIMUS (Mylan Pharmaceuticals)
            TACROLIMUS (NORTHSTAR RX LLC)
            TACROLIMUS (Panacea Biotec Limited)
            TACROLIMUS (Quallent Pharmaceuticals Health LLC)
            TACROLIMUS (REMEDYREPACK)
            TACROLIMUS (REMEDYREPACK)
            TACROLIMUS (REMEDYREPACK)
            TACROLIMUS (Sandoz)
            TACROLIMUS (Strides Pharma Science Limited)
            TACROLIMUS (Teva Pharmaceuticals USA)
FORMULA     C44H69NO12. H2O
EXACT_MASS  821.4925
MOL_WEIGHT  822.0334
SOURCE      Streptomyces tsukubaensis [TAX:83656]
CLASS       Immunological agent
             DG03129  Calcineurin inhibitor
            Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1319 2699 3999
            ATC code: D11AH01 L04AD02
            Chemical structure group: DG00439
            Product (DG00439): D00107<JP/US>
EFFICACY    Antiallergic, Immunosuppressant, Calcineurin inhibitor
  DISEASE   Organ rejection in kidney transplant [DS:H00083]
            Organ rejection in liver transplant [DS:H00083]
            Organ rejection in heart transplant [DS:H00083]
            Atopic dermatitis [DS:H01358]
COMMENT     Tacrolimus and FK506-binding protein [HSA:2280 2281] complex inhibits calcineurin.
TARGET      PPP3C/PPP3R/CHP [HSA:5530 5532 5533 5534 5535 11261 63928] [KO:K04348 K06268 K17610 K17611]
  PATHWAY   hsa04010(5530+5532+5533+5534+5535)  MAPK signaling pathway
            hsa04218(5530+5532+5533+5534+5535)  Cellular senescence
            hsa04380(5530+5532+5533+5534+5535)  Osteoclast differentiation
            hsa04650(5530+5532+5533+5534+5535)  Natural killer cell mediated cytotoxicity
            hsa04658(5530+5532+5533+5534+5535)  Th1 and Th2 cell differentiation
            hsa04659(5530+5532+5533+5534+5535)  Th17 cell differentiation
            hsa04660(5530+5532+5533+5534+5535)  T cell receptor signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07046  Immunosuppressive agents
            map07050  Antirheumatics - DMARDs and biological agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D11 OTHER DERMATOLOGICAL PREPARATIONS
               D11A OTHER DERMATOLOGICAL PREPARATIONS
                D11AH Agents for dermatitis, excluding corticosteroids
                 D11AH01 Tacrolimus
                  D00107  Tacrolimus (USP/INN) &lt;JP/US&gt;
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AD Calcineurin inhibitors
                 L04AD02 Tacrolimus
                  D00107  Tacrolimus (USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatitis and Pruitus Agents
               Dermatitis and Pruitus Agents, Other
                Tacrolimus
                 D00107  Tacrolimus (USP/INN)
             Immunological Agents
              Immunosuppressants
               Calcineurin Inhibitors
                Tacrolimus
                 D00107  Tacrolimus (USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D00107  Tacrolimus (USP/INN); Tacrolimus hydrate (JP18)
             2  Agents affecting individual organs
              26  Epidermides
               269  Miscellaneous
                2699  Others
                 D00107  Tacrolimus (USP/INN); Tacrolimus hydrate (JP18)
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D00107  Tacrolimus (USP/INN); Tacrolimus hydrate (JP18)
            Drug groups [BR:br08330]
             Immunological agent
              DG03129  Calcineurin inhibitor
               DG00439  Tacrolimus
                D00107  Tacrolimus
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG00439  Tacrolimus
                D00107  Tacrolimus
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00107  Tacrolimus
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00439  Tacrolimus
                 D00107  Tacrolimus
            Drug classes [BR:br08332]
             Immunological agent
              DG03129  Calcineurin inhibitor
               D00107  Tacrolimus
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D00107  Tacrolimus
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00107  Tacrolimus
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Phosphatases
                PPP3C/PPP3R/CHP
                 D00107  Tacrolimus (USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00107  Tacrolimus hydrate
              D00107  Tacrolimus capsules
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00107
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00107
            Drug groups [BR:br08330]
             Immunological agent
              DG03129  Calcineurin inhibitor
               DG00439  Tacrolimus
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG00439  Tacrolimus
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00439  Tacrolimus
DBLINKS     CAS: 109581-93-3
            PubChem: 7847175
            ChEBI: 61057
            LigandBox: D00107
            NIKKAJI: J1.629.005J
ATOM        58
            1   O0  O    31.6167  -21.2567
            2   C2c C    22.3300  -12.4600
            3   C2b C    22.3300  -11.0600
            4   C1y C    21.1400  -10.2900
            5   C1x C    21.1400   -8.8900
            6   C1x C    19.8800   -8.1900
            7   C1y C    18.6900   -8.8900
            8   C1y C    18.6900  -10.2900
            9   C1x C    19.8800  -11.0600
            10  O2a O    17.5000  -11.0600
            11  O1a O    17.5000   -8.1900
            12  C1a C    16.3100  -10.2900
            13  C1c C    23.5900  -13.1600
            14  C1a C    21.1400  -13.1600
            15  C1c C    24.7800  -12.4600
            16  C1c C    25.9700  -13.1600
            17  C1b C    25.9700  -14.5600
            18  C5a C    27.3000  -15.1200
            19  C1c C    27.9300  -16.4500
            20  C2b C    27.2300  -17.7100
            21  C2c C    25.9700  -18.4100
            22  C1a C    24.7800  -17.7100
            23  C1b C    25.9700  -19.8100
            24  C1c C    24.7800  -20.5100
            25  C1a C    23.5900  -19.8100
            26  C1b C    25.4800  -21.7000
            27  C1c C    24.5000  -22.8200
            28  C1y C    23.1700  -22.4000
            29  C1y C    22.1200  -23.4500
            30  C1x C    20.7900  -23.1000
            31  C1y C    20.4400  -21.7000
            32  C1z C    21.4200  -20.7200
            33  O2x O    22.8200  -21.0700
            34  O2a O    22.5400  -24.7800
            35  O2a O    24.8500  -24.1500
            36  C1a C    26.1800  -24.5700
            37  C1a C    21.4900  -25.7600
            38  O1a O    22.6800  -20.0900
            39  C5a C    20.7200  -19.5300
            40  C5a C    21.4200  -18.2700
            41  N1y N    20.7200  -17.0800
            42  C1x C    19.3200  -17.0800
            43  C1y C    21.4200  -15.8900
            44  C1x C    20.7200  -14.6300
            45  C1x C    19.3200  -14.6300
            46  C1x C    18.6200  -15.8200
            47  O5a O    22.8900  -18.2700
            48  O5a O    19.3200  -19.5300
            49  C1a C    19.0400  -21.3500
            50  C7a C    22.8900  -15.8900
            51  O6a O    23.5900  -17.0800
            52  O7a O    23.5900  -14.6300
            53  C1a C    24.7800  -11.0600
            54  O1a O    27.1600  -12.4600
            55  O5a O    28.3500  -14.3500
            56  C1b C    29.3300  -16.4500
            57  C2b C    30.1000  -15.3300
            58  C2a C    31.4300  -15.2600
BOND        60
            1     2   3 2
            2     4   3 1 #Up
            3     4   5 1
            4     5   6 1
            5     6   7 1
            6     7   8 1
            7     8   9 1
            8     4   9 1
            9     8  10 1 #Up
            10    7  11 1 #Down
            11   10  12 1
            12    2  13 1
            13    2  14 1
            14   13  15 1
            15   15  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 1
            19   19  20 1
            20   20  21 2
            21   21  22 1
            22   21  23 1
            23   23  24 1
            24   24  25 1 #Up
            25   24  26 1
            26   26  27 1
            27   27  28 1
            28   28  29 1
            29   29  30 1
            30   30  31 1
            31   31  32 1
            32   32  33 1
            33   33  28 1
            34   29  34 1 #Up
            35   27  35 1 #Down
            36   35  36 1
            37   34  37 1
            38   32  38 1 #Up
            39   32  39 1
            40   39  40 1
            41   42  41 1
            42   41  43 1
            43   43  44 1
            44   44  45 1
            45   45  46 1
            46   42  46 1
            47   40  41 1
            48   40  47 2
            49   39  48 2
            50   31  49 1 #Up
            51   43  50 1
            52   50  51 2
            53   50  52 1
            54   13  52 1 #Down
            55   15  53 1 #Down
            56   16  54 1 #Up
            57   18  55 2
            58   19  56 1 #Down
            59   56  57 1
            60   57  58 2
///
